REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
Source: insidermonkey.com
Vit Vasista News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Vit Vasista. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Vit Vasista Today - Breaking & Trending Today
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2022 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Q4 and Full Year 2022 REGENXBIO Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Regenxbio Inc. (RGNX) Q4 2020 Earnings Call Transcript
Operator [Operator Instructions] I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer for REGENXBIO. You may begin. Patrick J. Christmas -- Good afternoon and thank you for joining us today. With us are Ken Mills, REGENXBIO's President and Chief Executive Officer, Dr. Steve Pakola, our Chief Medical Officer, Dr. Olivier Danos our Chief Scientific Officer, and Vit Vasista, our Chief Financial Officer. Earlier this afternoon, REGENXBIO released financial and operating results for the fourth quarter and full year ended December 31, 2020. The press release reporti...
Source: fool.com